Merck & Co's first victory in the massive litigation over its painkiller Vioxx gives the pharmaceutical company a psychological lift and a short-term stock boost -- and also plenty of uncertainty as it still faces thousands of future lawsuits.
What is certain, given Merck's repeated assertions that it will fight the thousands of Vioxx suits one by one, is that the world's fifth-biggest drug maker will spend hundreds of millions of dollars to defend itself as legal costs mount.
After deliberating for less than eight hours over three days, a New Jersey state jury on Thursday cleared the nation's No. 5 pharmaceutical company of allegations it failed to warn consumers about the drug's risks and engaged in "unconscionable commercial practices" in marketing it to doctors and their patients.
PHOTO: AP
Much of the seven-week New Jersey trial, eagerly watched by lawyers and plaintiffs from around the country, relied on the testimony of medical experts. Witnesses for Merck testified the company believed Vioxx was safe for the heart before the drug was pulled from the market in response to a study that showed it doubled risk of heart attacks and strokes when taken for at least 18 months.
Barbara Ryan, pharmaceuticals analyst at Deutsche Bank North America, estimated the New Jersey-based company's liability over Vioxx at US$15 billion to US$30 billion on Thursday.
"I do think that Merck has a good defense in the litigation," she said. "It's still going to be a marathon."
Merck was clearly elated by its victory.
"We feel very much vindicated," Merck general counsel Kenneth Frazier said. "The jury found in our favor, we believe, because the evidence showed that Merck acted responsibly."
Frazier said Merck will fight each lawsuit individually, adding that mass settlements aren't appropriate because facts in each case differ.
"There's an awful lot at stake, not just for Merck," but for the pharmaceutical industry and patients, he said, claiming floods of lawsuits can discourage scientific research and keep needed drugs off the market.
Merck's stock rose US$1.07, or 3.8 percent, to US$29.48 after the verdict. More than 32 million shares changed hands in barely two hours on the New York Stock Exchange -- about four times the stock's normal daily volume.
The verdict came 2 1/2 months after Merck loss a Vioxx case in Texas. The split verdicts mean it will likely take at least several more cases before lawyers can determine if there are any precedents to be followed in future litigation.
The first federal Vioxx trial is scheduled to start Nov. 28 in Houston.
Ryan and some other analysts said Merck's win might discourage some future lawsuits by former Vioxx users who had cases similar to Frederick "Mike" Humeston, a Boise, Idaho, postal worker.
That would include people who survived and who took the drug for less than 18 months, the point at which Merck's own research shows Vioxx use doubled risk of heart attack and stroke.
Merck general counsel Kenneth Frazier told reporters in a conference call he believes most of the cases filed so far -- more than 7,000, with half filed in New Jersey state court -- involve plaintiffs who took Vioxx for less than 18 months.
Independent health-care analyst Hemant Shah of HKS & Co in Warren, New Jersey, said Thursday's verdict was more a psychological boost than anything else for Merck.
"I don't think it's going to have any immediate impact" on the number of new suits filed, he said. "There are attorneys who are looking for work," and plaintiffs don't have to front any of the legal costs.
The government is aiming to recruit 1,096 foreign English teachers and teaching assistants this year, the Ministry of Education said yesterday. The foreign teachers would work closely with elementary and junior-high instructors to create and teach courses, ministry official Tsai Yi-ching (蔡宜靜) said. Together, they would create an immersive language environment, helping to motivate students while enhancing the skills of local teachers, she said. The ministry has since 2021 been recruiting foreign teachers through the Taiwan Foreign English Teacher Program, which offers placement, salary, housing and other benefits to eligible foreign teachers. Two centers serving northern and southern Taiwan assist in recruiting and training
RESTAURANT POISONING? Deputy Minister of Health and Welfare Victor Wang at a press conference last night said this was the first time bongkrekic acid was detected in Taiwan An autopsy discovered bongkrekic acid in a specimen collected from a person who died from food poisoning after dining at the Malaysian restaurant chain Polam Kopitiam, the Ministry of Health and Welfare said at a news conference last night. It was the first time bongkrekic acid was detected in Taiwan, Deputy Minister of Health and Welfare Victor Wang (王必勝) said. The testing conducted by forensic specialists at National Taiwan University was facilitated after a hospital voluntarily offered standard samples it had in stock that are required to test for bongkrekic acid, he said. Wang told the news conference that testing would continue despite
WIDE NET: Health officials said they are considering all possibilities, such as bongkrekic acid, while the city mayor said they have not ruled out the possibility of a malicious act of poisoning Two people who dined at a restaurant in Taipei’s Far Eastern Department Store Xinyi A13 last week have died, while four are in intensive care, the Taipei Department of Health said yesterday. All of the outlets of Malaysian vegetarian restaurant franchise Polam Kopitiam have been ordered to close pending an investigation after 11 people became ill due to suspected food poisoning, city officials told a news conference in Taipei. The first fatality, a 39-year-old man who ate at the restaurant on Friday last week, died of kidney failure two days later at the city’s Mackay Memorial Hospital. A 66-year-old man who dined
‘CARRIER KILLERS’: The Tuo Chiang-class corvettes’ stealth capability means they have a radar cross-section as small as the size of a fishing boat, an analyst said President Tsai Ing-wen (蔡英文) yesterday presided over a ceremony at Yilan County’s Suao Harbor (蘇澳港), where the navy took delivery of two indigenous Tuo Chiang-class corvettes. The corvettes, An Chiang (安江) and Wan Chiang (萬江), along with the introduction of the coast guard’s third and fourth 4,000-tonne cutters earlier this month, are a testament to Taiwan’s shipbuilding capability and signify the nation’s resolve to defend democracy and freedom, Tsai said. The vessels are also the last two of six Tuo Chiang-class corvettes ordered from Lungteh Shipbuilding Co (龍德造船) by the navy, Tsai said. The first Tuo Chiang-class vessel delivered was Ta Chiang (塔江)